IDEAYA Biosciences, Inc.
Status: Publicly traded
Direct answer
IDEAYA Biosciences, Inc. is publicly traded on NASDAQ under the ticker IDYA.
IDEAYA Biosciences, Inc. is a precision oncology company primarily dedicated to identifying and advancing targeted therapies, particularly leveraging the concept of synthetic lethality. The firm aims to develop specific treatments for patient groups selected through molecular diagnostic methods. At the forefront of its clinical efforts are two investigational drugs. IDE397, a methionine adenosyltransferase 2a...
Can you invest in IDEAYA Biosciences, Inc.?
Yes. IDEAYA Biosciences, Inc. trades publicly on NASDAQ as IDYA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for IDEAYA Biosciences, Inc.
Detailed equity research is provided by MarketSnap.